Testing a new platform to screen disease-modifying therapy in type 1 diabetes. Lord SM, Bahnson HT, Greenbaum CJ, Liljenquist DR, et al. PLoS One 2023;18:e0293268.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lord SM, Bahnson HT, Greenbaum CJ, Liljenquist DR, et al. Testing a new platform to screen disease-modifying therapy in type 1 diabetes. PLoS One 2023;18:e0293268.
PMID: 38096190